We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $748M
1-Year Est. Return 27.21%
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
+27.21%
3 Year Est. Return
+69.53%
5 Year Est. Return
+110.76%
10 Year Est. Return
–
AUM
$275M
AUM Growth
+$7.11M
Cap. Flow
+$3.53M
Cap. Flow %
1.28%
Top 10 Hldgs %
30.46%
Holding
75
New
–
Increased
32
Reduced
36
Closed
1

Top Buys

Rank Stock Value
1
KDP icon
Keurig Dr Pepper
KDP
+$1.54M
2
CLB icon
Core Laboratories
CLB
+$1.33M
3
DLX icon
Deluxe
DLX
+$1.32M
4
SEIC icon
SEI Investments
SEIC
+$758K
5
GPN icon
Global Payments
GPN
+$645K

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$1.65M
2
CSCO icon
Cisco
CSCO
+$1.44M
3
ALTR
Altera Corp
ALTR
+$658K
4
GILD icon
Gilead Sciences
GILD
+$519K
5
OXY icon
Occidental Petroleum
OXY
+$452K

Sector Composition

Rank Sector Weight
1 Healthcare 20.51%
2 Technology 18.87%
3 Industrials 18.47%
4 Consumer Discretionary 15.68%
5 Consumer Staples 11.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$187B
$9.77M 3.55%
117,784
-6,673
-5% -$519K
ORCL icon
2
Oracle
ORCL
$457B
$9.41M 3.42%
232,136
+2,586
+1% +$106K
MA icon
3
Mastercard
MA
$507B
$9.08M 3.3%
123,549
+2,148
+2% +$160K
MKC icon
4
McCormick & Company Non-Voting
MKC
$14B
$8.46M 3.07%
236,462
+3,910
+2% +$140K
NEU icon
5
NewMarket
NEU
$8.14B
$8.42M 3.06%
21,484
+395
+2% +$152K
CTSH icon
6
Cognizant
CTSH
$28.1B
$8.32M 3.02%
170,191
+5,541
+3% +$270K
AME icon
7
Ametek
AME
$54.5B
$7.92M 2.88%
151,529
-876
-0.6% -$46K
MSFT icon
8
Microsoft
MSFT
$3.71T
$7.68M 2.79%
184,098
-306
-0.2% -$12.4K
APH icon
9
Amphenol
APH
$204B
$7.42M 2.7%
1,233,168
+4,560
+0.4% +$27.2K
ACN icon
10
Accenture
ACN
$114B
$7.42M 2.69%
91,798
-27
-0% -$2.17K
AAPL icon
11
Apple
AAPL
$4.67T
$7.41M 2.69%
318,868
+14,088
+5% +$300K
GGG icon
12
Graco
GGG
$12.6B
$7.16M 2.6%
274,944
+7,077
+3% +$175K
PEP icon
13
PepsiCo
PEP
$188B
$6.96M 2.53%
77,881
+866
+1% +$74.8K
PII icon
14
Polaris
PII
$3.56B
$6.73M 2.44%
51,654
+935
+2% +$124K
OA
15
DELISTED
Orbital ATK, Inc.
OA
$6.61M 2.4%
49,336
-470
-0.9% -$64.8K
SEIC icon
16
SEI Investments
SEIC
$13.2B
$6.01M 2.18%
183,453
+23,531
+15% +$758K
ROL icon
17
Rollins
ROL
$17.3B
$5.99M 2.17%
673,630
+7,138
+1% +$64.1K
SYK icon
18
Stryker
SYK
$116B
$5.91M 2.14%
70,049
-915
-1% -$74.7K
VAR
19
DELISTED
Varian Medical Systems, Inc.
VAR
$5.9M 2.14%
80,944
+2,590
+3% +$186K
TTC icon
20
Toro Company
TTC
$8.83B
$5.88M 2.13%
184,800
+5,240
+3% +$167K
NKE icon
21
Nike
NKE
$57B
$5.83M 2.12%
150,284
-1,666
-1% -$62K
BCR
22
DELISTED
CR Bard Inc.
BCR
$5.72M 2.08%
40,024
-350
-0.9% -$50K
SLGN icon
23
Silgan Holdings
SLGN
$4.35B
$5.37M 1.95%
211,474
+1,598
+0.8% +$39.6K
ROST icon
24
Ross Stores
ROST
$73.7B
$5.17M 1.88%
156,454
+2,016
+1% +$69.2K
TJX icon
25
TJX Companies
TJX
$145B
$4.85M 1.76%
182,534
+10,718
+6% +$306K
1
2 3

Similar funds

VCM
Virtue Capital Management Brentwood, Tennessee $749M AUM 40.13% 1-Year Est. Return
QI
Qtron Investments Boston, Massachusetts $750M AUM 44.01% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
BCM
Bienville Capital Management New York $750M AUM 2.59% 1-Year Est. Return
BG
BDF Gestion Paris, France $747M AUM 47.35% 1-Year Est. Return
PCM
Permanent Capital Management Chicago, Illinois $747M AUM 17.94% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

JLB & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, JLB & Associates held 75 positions worth $275M, up 2.6% from $268M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q2 2014: portfolio turnover was 1.3%. JLB & Associates opened no new positions and exited 1, leaving the 75-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.

  • JLB & Associates added most to Keurig Dr Pepper in Q2 2014, an estimated $1.54M increase.
  • JLB & Associates's biggest Q2 2014 reduction was Abbott, cutting an estimated $1.65M.
  • JLB & Associates fully exited QUESTCOR PHARMA INC in Q2 2014, selling an estimated $393K.
  • JLB & Associates's ten largest holdings make up 30% of its $275M portfolio in Q2 2014.
  • JLB & Associates opened 0 new positions and closed 1 in Q2 2014.
  • JLB & Associates's portfolio value rose 2.6% quarter-over-quarter to $275M.

Based on JLB & Associates's 13F filing for Q2 2014, filed 11 Jul 2014.